openPR Logo
Press release

Biosimulation Market CAGR of 15.1% | Physiomics, Evidera, In Silico Biosciences, Leadinvent Technologies, Inosim Software

03-17-2020 01:20 PM CET | Health & Medicine

Press release from: Data Bridge Market Research

Biosimulation Market

Biosimulation Market

The Global Biosimulation Market is expected to reach USD 4.25 Billion by 2025 from USD 1.38 Billion in 2017 growing at a CAGR of 15.1% during the forecast period of 2018 to 2025. Global Biosimulation Market, By Product and Service (Software, Services), By Application (Drug Development, Drug Discovery, Others), By Delivery Model (Subscription Models, Ownership Models), By End Users (Pharmaceutical & Biotechnology Companies, Research Institutes, Others) By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa- Industry Trends and Forecast to 2025

Download exclusive PDF sample report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-biosimulation-market

Some of the key players operating in the market are Certara, Simulation Plus, Dassault Systmes, Schrdinger, Advanced Chemistry Development, Chemical Computing Group, Rosa, Physiomics, Evidera, In Silico Biosciences, Leadinvent Technologies, Inosim Software, Nuventra Pharma, Accelrys, Entelos, Physiomics, Rhenovia, Insilico Biotechnology, LeadScope, Genedata, Archimedes, Compugen among others.

Market Definition: Global Biosimulation Market

Biosimulation is a mathematical model of biological processes. It provides information about dose precision, drug-drug interaction at molecular level as well as physiological based pharmaceutical pharmacokinetic modelling (PBPK). The aim of bio simulation is to help in predicting behavior and dynamics of biological system. Various technological advancements are taking place in biosimulation market. Such as, in August 2013, Certara Inc made an agreement with The Hammer Institute for Health Sciences. This agreement l merged Hamner's DILIsym modeling software into Certara's Simcyp population-based simulator and integrates product simulation capabilities. In January 2013, Thomson and Reuters entered into an agreement with Certara Inc. In this agreement Certara gained an access to data in Thomson Reuter's Cortellis In April 2016, Simulation Plus, Inc. launched the DDDPlus Version 5.0, invitro dissolution experiment software. This product launch helped the company to add new functionalities in the formulation of drug in both innovator and generic drug companies In July 2017, EQT acquired Certara Inc. Under this agreement both the company will focus on drug development processes and improving the health outcomes.

Major Market Drivers and Restraints:

Increase in R&D investment in pharmaceutical and biotechnology industry.
Increase in adoption of biosimulation software by regulatory bodies
Technological advancement QSP systems
Growth in development of biologics and biosimilar
Shortage of biosimulation and modeling experts
Increased use of personalized medicine

To Buy Complete Report Click Here @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-biosimulation-market

Market Segmentation: Global Biosimulation Market

The biosimulation market is segmented into products and services, application, delivery model and end users.

Based on products and services, the market is segmented into software and services. Software segment is further sub segmented into trial design software, toxicity prediction software, PBPK modeling & simulation software, molecular modeling and simulation software, PK/PD modeling & simulation software. Services are further segmented into in-house services and contract services.

Based on application, the market is segmented into drug development, drug discovery and others. Drug development is further sub-segmented into preclinical testing and clinical trials. Preclinical testing is further sub-segmented into PK/PD and ADME/TOX. Drug discovery is further sub-segmented into target identification & validation, lead identification and optimization.

Based on delivery model, the market is segmented into subscription models and ownership models.

Based on end-users, the market is segmented into pharmaceutical & biotechnology companies, research institutes, contract research organizations, regulatory authorities and others

Based on geography the biosimulation market report covers data points for 28 countries across multiple geographies namely North America & South America, Europe, Asia-Pacific and, Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa and, Brazil among others.

Competitive Analysis:?Global Biosimulation Market

The global biosimulation market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions and others to increase their footprints in this market. The report includes market shares of biosimulation system market for global, Europe, North America, Asia Pacific and South America.

Table of Contents

Introduction
Market Segmentation
Market Overview
Executive Summary
Premium Insights
Global, By Component
Product Type
Delivery
Industry Type
Geography

Get Full TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-biosimulation-market

Contact:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email: Corporatesales@databridgemarketresearch.com

About Data Bridge Market Research

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Biosimulation Market CAGR of 15.1% | Physiomics, Evidera, In Silico Biosciences, Leadinvent Technologies, Inosim Software here

News-ID: 1971345 • Views:

More Releases from Data Bridge Market Research

Swine Feed Acidulants Market Size, Share, and Trends Analysis Report to Observe Prominent CAGR of 5.80% by 2029, Size, Share, Trends, Demand, Growth, Challenges and Competitive Outlook
Swine Feed Acidulants Market Size, Share, and Trends Analysis Report to Observe …
Data Bridge Market Research analyses that the swine feed acidulants market will project a compound annual growth rate (CAGR) of 5.80% during the forecast period of 2022-2029. Market Definition: Feed acidulants are the compounds that are added to the animal feed to improve the taste, texture, enhance the flavour, improve shelf life and improve the solubility rate. Feed acidulants decrease the pH level by discharging hydrogen in water. Browse More About This Research
Robotic Surgery for Endometrial Cancer Market Size, Share, and Trends Analysis Report to Observe Prominent CAGR of 13.80% by 2032, Size, Share, Trends, Demand, Growth, Challenges and Competitive Outlook
Robotic Surgery for Endometrial Cancer Market Size, Share, and Trends Analysis R …
Robotic surgery for endometrial cancer market size was valued at USD 7.96 billion in 2024 and is projected to reach USD 22.39 billion by 2032, with a CAGR of 13.80% during the forecast period of 2025 to 2032. Market Definition: Robotic surgery for endometrial cancer has less blood loss, shorter hospital stays, and less postoperative complications compared to laparotomies. Robotic technologic advantages over laparoscopic technique are most pronounced in obese patients. The
Carboxylic Acids Based Esters Market Size, Share, and Trends Analysis Report to Observe Prominent CAGR of 4.5% by 2030, Size, Share, Trends, Demand, Growth, Challenges and Competitive Outlook
Carboxylic Acids Based Esters Market Size, Share, and Trends Analysis Report to …
Data Bridge Market Research analyses that the global carboxylic acids based esters market which was USD 3.5 billion in 2022, is expected to reach USD 4.93 billion by 2030, growing at a CAGR of 4.5% during the forecast period of 2023 to 2030. Market Definition: Carboxylic acids based esters are chemical compounds derived from carboxylic acids, which are organic compounds containing the carboxyl functional group (COOH). Esters are formed by the reaction
Allergy Diagnostics Market to Observe Prominent CAGR in the 11.22% by 2031, Size, Share, Trends, Demand, Growth, Challenges and Competitive Outlook
Allergy Diagnostics Market to Observe Prominent CAGR in the 11.22% by 2031, Size …
Allergy diagnostics market size was valued at USD 5.94 billion in 2023 and is projected to reach USD 13.90 billion by 2031, with a CAGR of 11.22% during the forecast period of 2024 to 2031. Market Definition: In medical terms, an allergy is defined as a systemic sensitivity disease. An allergy diagnosis is a test performed by a qualified allergy specialist to determine if the patient's body is allergic to any known

All 5 Releases


More Releases for Biosimulation

Global Biosimulation Market to witness digitized satiation
In the process of biosimulation, the computer aided mathematical models are used to simulate the biological processes. Biosimulation is an important part of systems biology and helps in the discovery and development of new drugs, in the area of drug metabolism and in the modeling of biomedical systems that are complex. There is a growing demand for reduction in the cost of discovery of new drugs and the risk of failure
The Biosimulation Market to Be Driven By Neurotechnology
The Biosimulation Market is slated to grow unstoppably in the years to come. The healthcare providers are, of late, making way for more specialized and timely treatment through same-day surgeries, outpatient surgeries, and likewise. ASCs (Ambulatory Surgical Centers) are preferred over conventional hospital settings. As such, cost-effective medical services could be provided. This type of customization is expected to take the healthcare vertical by storm in the future. In the process
The Biosimulation Market to stick to digitized innovation
The Biosimulation Market taught to grow sporadically shortly. With improvement in machine-powered analytics, the healthcare vertical is bound to substantiate therein. Machine learning does make caregivers able of putting data to use, thereby enhancing patients’ outcomes along with overall efficiency. This would be the trend in the healthcare vertical going forward. Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/methodology/3726 In the process of biosimulation, the computer aided mathematical models are used to simulate
Biosimulation Market Study: An Emerging Hint of Opportunity
Latest released the research study on Global Biosimulation Market, offers a detailed overview of the factors influencing the global business scope. Biosimulation Market research report shows the latest market insights, current situation analysis with upcoming trends and breakdown of the products and services. The report provides key statistics on the market status, size, share, growth factors of the Biosimulation. The study covers emerging player’s data, including: Certara, L.P., Simulations Plus,
Biosimulation Market Growth and Sales Forecast 2016 - 2014
Global Biosimulation Market: Overview Biosimulation refers to the mathematical simulation of biological processes and systems. It is aided by computer and is used for model based calculation of biological systems and processes. TMR’s latest report forecasts strong growth for the global biosimulation market between 2011 and 2018. The market is expected to significantly gain from the increasing use of pharmacokinetic (PKPD) and pharmacodynamics, of which PKPD is the most widely used
Biosimulation Market Size, Industry Analysis & Forecast Report 2017
Biosimulation Market Outlook To 2024 ReportsMonitor.com has added the report, “Biosimulation Market Outlook To 2024: Key Categories (Software, Services), by Application, by End-Use, Regional Segmentation, Pipeline Analysis, Competitive Dynamics, And Segment Forecast” extend across over 103 pages, the far reaching research study offers a 360-degree analysis of the market crosswise over different unequivocal elements, including market share by segmentation type, cost analysis, market effect factors, and marketing strategy and promoting methodology. The